Decoy Therapeutics Inc.
corporate_fare Company Profile
Decoy Therapeutics Inc. (NASDAQ:DCOY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for DCOY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-23, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 10/10, with 14 rated 8 or above. Recent SEC coverage for DCOY spans 8-K, 10-Q, PRE 14A, S-1.
Recent high-impact activity:
- Decoy Therapeutics Closes $3.85M Warrant Inducement, Issues 2.37M New Warrants
- Decoy Therapeutics Raises $3.85M via Warrant Inducement at $3.25
- Decoy Therapeutics Reports Q2 Loss, Going Concern Warning, and Nasdaq Delisting Risk
- D-MAV Platform Shows Cross-Viral Activity Against Ebola, Opening New Pandemic Preparedness Program
- Decoy Therapeutics seeks stockholder approval for up to 2.96 million warrant shares and a reduction in authorized shares
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 10,578 shares in DCOY as of the September 15, 2026 settlement, a 19.6% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 44.7% of DCOY volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for DCOY, detected from its recent SEC filings · based on capital-structure filings through 2026-07-24.
Warrant Exercise Vote Sought · Massive Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →